Investor Information

 

Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the 

  • TSX Venture Exchange (TLT-TSXV) and the
  • OTCQB (TLTFF)

Data last updated on March 14, 2020


 

Number of common shares outstanding

Basic: 204,275,375

Warrants: 91,814,705

Options: 16,920,000 

Fully Diluted: 313,010,080

Insider Ownership: 7% (9.3% fully diluted)

[stockdio-historical-chart]

Financial Filings

 
Downloaded 275 times.
Downloaded 269 times.
Downloaded 265 times.
Downloaded 505 times.
Downloaded 334 times.
Downloaded 265 times.
Downloaded 265 times.
Downloaded 173 times.
Downloaded 101 times.
Downloaded 265 times.
Downloaded 55 times.
Downloaded 10 times.
Downloaded 9 times.
Downloaded 13 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 3 times.
Downloaded 3 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 2 times.
Downloaded 2 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 6 times.
 
Downloaded 191 times.
Downloaded 184 times.
Downloaded 181 times.
Downloaded 284 times.
Downloaded 181 times.
Downloaded 181 times.
Downloaded 181 times.
Downloaded 122 times.
Downloaded 79 times.
Downloaded 45 times.
Downloaded 38 times.
Downloaded 4 times.
Downloaded 6 times.
Downloaded 7 times.
Downloaded 0 times.
Downloaded 4 times.
Downloaded 0 times.
Downloaded 2 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 1 times.
Downloaded 3 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 7 times.
SEDAR Filings (System for Electronic Document Analysis and Retrieval)

Theralase's complete public securities documents are available in English and French on SEDAR.